InsiderClue
Insiders · Profile

ROCKLAGE SCOTT M

Director at Aprea Therapeutics · Director at Pulmatrix. Filing since 16 Jun 2015. CIK 0001219014

APRE Aprea Therapeutics, Inc. Director · 3 trades PULM Pulmatrix, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
APRE Aprea Therapeutics, Inc.
16 Jun 2020
Director
Sold, plan not stated
120,164
$4.00M
61.3%
APRE Aprea Therapeutics, Inc.
11 Jun 2020
Director
Sold, plan not stated
245,000
$7.04M
75.2%
APRE Aprea Therapeutics, Inc.
19 May 2020
Director
Sold, plan not stated
255,000
$8.96M
73.8%
PULM Pulmatrix, Inc.
16 Jun 2015
Director
Bought
38,805
$266.78K
3.4%
4 decisions on file.